Differential Effects of Ramipril on Ambulatory Blood Pressure in African Americans and Caucasians

American Journal of Hypertension

Volumn 20, Issue 8, 2007, Pages 884-891

  Moran, Andrew ^a,b   Simon, Joel A ^b   Shiboski, Stephen ^a   Pickering, Thomas G ^c,d   Waters, David ^a   Rotter, Jerome I ^e,f   Lyon, Christopher ^e   Nickerson, Deborah ^g   Yang, Huiying ^e,f   Saad, Mohammed ^h   Hsueh, Willa ^e   Krauss, Ronald M ⁱ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Columbia University ^*  (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h STONY BROOK UNIVERSITY   (United States)

ⁱ CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

African American; Ambulatory blood pressure; angiotensin converting enzyme inhibitors; Caucasian; nondipping; pharmacotherapy

Indexed keywords

ALDOSTERONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL; SODIUM;

ADULT; AFRICAN AMERICAN; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CAUCASIAN; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NIGHT; PRIORITY JOURNAL; RACE DIFFERENCE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

AFRICAN AMERICANS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RAMIPRIL; TREATMENT OUTCOME; UNITED STATES;

EID: 34547394945     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2007.02.006     Document Type: Article

References (30)

1. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., Jones D.W., Materson B.J., Oparil S., Wright Jr. J.T., and Roccella E.J. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
2. Gross J.L., de Azevedo M.J., Silveiro S.P., Canani L.H., Caramori M.L., and Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28 (2005) 164-176
3. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43 Suppl 1 (2004) S1-S290
4. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., Jessup M., Konstam M.A., Mancini D.M., Michl K., Oates J.A., Rahko P.S., Silver M.A., Stevenson L.W., Yancy C.W., Antman E.M., Smith Jr. S.C., Adams C.D., Anderson J.L., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Jacobs A.K., Nishimura R., Ornato J.P., Page R.L., and Riegel B. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure); developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation; endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
5. Mokwe E., Ohmit S.E., Nasser S.A., Shafi T., Saunders E., Crook E., Dudley A., and Flack J.M. Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation Trial. Hypertension 43 (2004) 1202-1207
6. Saunders E., Weir M.R., Kong B.W., Hollifield J., Gray J., Vertes V., Sowers J.R., Zemel M.B., Curry C., Schoenberger J., Wright J.T., Kirkendall W., Conradi E.C., Jenkins P., McLean B., Massie B., Berenson G., and Flamenbaum W. A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 150 (1990) 1707-1713
7. Wright Jr. J.T., Dunn J.K., Cutler J.A., Davis B.R., Cushman W.C., Ford C.E., Haywood L.J., Leenen F.H., Margolis K.L., Papademetriou V., Probstfield J.L., Whelton P.K., and Habib G.B. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA 293 (2005) 1595-1608
8. Materson B.J., Reda D.J., Cushman W.C., Massie B.M., Freis E.D., Kochar M.S., Hamburger R.J., Fye C., Lakshman R., Gottdiener J., Ramirez E.A., Henderson W.G., and The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 328 (1993) 914-921
9. Staessen J.A., Byttebier G., Buntinx F., Celis H., O'Brien E.T., Fagard R., and Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. JAMA 278 (1997) 1065-1072
10. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 35 (2000) 844-851
11. Gretler D.D., Fumo M.T., Nelson K.S., and Murphy M.B. Ethnic differences in circadian hemodynamic profile. Am J Hypertens 7 (1994) 7-14
12. Profant J., and Dimsdale J.E. Race and diurnal blood pressure patterns. A review and meta-analysis. Hypertension 33 (1999) 1099-1104
13. Witte K., Weisser K., Neubeck M., Mutschler E., Lehmann K., Hopf R., and Lemmer B. Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther 54 (1993) 177-186
14. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157 (1997) 2413-2446
15. Palatini P., Frigo G., Bertolo O., Roman E., Da Corta R., and Winnicki M. Validation of the A&D TM-2430 device for ambulatory blood pressure monitoring and evaluation of performance according to subjects' characteristics. Blood Press Monit 3 (1998) 255-260
16. Silverman B. Density Estimation for Statistics and Data Analysis (1986), Chapman and Hall, London
17. Efron B.T.R. An Introduction to the Bootstrap (1993), Chapman and Hall, New York
18. Mayet J., Chapman N., Li C.K., Shahi M., Poulter N.R., Sever P.S., Foale R.A., and Thom S.A. Ethnic differences in the hypertensive heart and 24-hour blood pressure profile. Hypertension 31 (1998) 1190-1194
19. Thomas K.S., Nelesen R.A., and Dimsdale J.E. Relationships between hostility, anger expression, and blood pressure dipping in an ethnically diverse sample. Psychosom Med 66 (2004) 298-304
20. van der Steen M.S., Pleijers A.M., Lenders J.W., and Thien T. Influence of different supine body positions on blood pressure: consequences for night blood pressure/dipper-status. J Hypertens 18 (2000) 1731-1736
21. Pedulla M., Silvestri R., Lasco A., Mento G., Lanuzza B., Sofia L., and Frisina N. Sleep structure in essential hypertensive patients: differences between dippers and non-dippers. Blood Press 4 (1995) 232-237
22. Frisina N., Pedulla M., Mento G., and Lanuzza B. Frequency domain of heart rate and blood pressure variability in essential hypertensive patients during sleep: differences between dippers and non-dippers. Blood Press Monit 1 (1996) 425-431
23. Meredith P.A., Donnelly R., Elliott H.L., Howie C.A., and Reid J.L. Prediction of the antihypertensive response to enalapril. J Hypertens 8 (1990) 1085-1090
24. Weir M.R., and Saunders E. Pharmacologic management of systemic hypertension in blacks. Am J Cardiol 61 (1988) 46H-52H
25. Weir M.R. Impact of age, race, and obesity on hypertensive mechanisms and therapy. Am J Med 90 Suppl 5A (1991) 3S-14S
26. Weir M.R., Saunders E., and Trandolapril Multicenter Study Group. Renin status does not predict the anti-hypertensive response to angiotensin-converting enzyme inhibition in African-Americans. J Hum Hypertens 12 (1998) 189-194
27. Preston R.A., Materson B.J., Reda D.J., Williams D.W., Hamburger R.J., Cushman W.C., Anderson R.J., and Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. JAMA 280 (1998) 1168-1172
28. Weir M.R., Gray J.M., Paster R., Saunders E., and The Trandolapril Multicenter Study Group. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. Hypertension 26 (1995) 124-130
29. Sehgal A.R. Overlap between whites and blacks in response to antihypertensive drugs. Hypertension 43 (2004) 566-572
30. Douglas J.G., Bakris G.L., Epstein M., Ferdinand K.C., Ferrario C., Flack J.M., Jamerson K.A., Jones W.E., Haywood J., Maxey R., Ofili E.O., Saunders E., Schiffrin E.L., Sica D.A., Sowers J.R., and Vidt D.G. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 163 (2003) 525-541